Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines
Clinical trial NCT05155579 · COMPLETED
Trial details
- NCT number
- NCT05155579
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-14
- Primary completion
- 2025-05-27
- Enrollment
- 594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.